An experimental coronavirus vaccine from drugmaker CanSino Biologics Inc. showed promising results in a preliminary human study, a sign that China is advancing toward playing a key early role stopping the global pandemic.
CanSino’s vaccine appeared safe for use and produced an immune response in most of the 108 healthy volunteers, according to the new study published Friday by the journal The Lancet.
It…
